IN2014DN11183A - - Google Patents
Download PDFInfo
- Publication number
- IN2014DN11183A IN2014DN11183A IN11183DEN2014A IN2014DN11183A IN 2014DN11183 A IN2014DN11183 A IN 2014DN11183A IN 11183DEN2014 A IN11183DEN2014 A IN 11183DEN2014A IN 2014DN11183 A IN2014DN11183 A IN 2014DN11183A
- Authority
- IN
- India
- Prior art keywords
- mixture
- compound
- cyclic macrolide
- macrolide compound
- silica gel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3833—Chiral chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
- B01J20/29—Chiral phases
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3204—Inorganic carriers, supports or substrates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/328—Polymers on the carrier being further modified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2253/00—Adsorbents used in seperation treatment of gases and vapours
- B01D2253/10—Inorganic adsorbents
- B01D2253/106—Silica or silicates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
- G01N2030/884—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample organic compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Transplantation (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Provided is a method whereby a target cyclic macrolide compound can be separated without using a silver compound even from a mixture that contains a compound having a double bond similar to the target cyclic macrolide compound. The method for separating a cyclic macrolide compound from a mixture said mixture containing the cyclic macrolide compound together with one or more kinds of analogous compounds thereof is characterized in that the mixture is subjected to silica gel column chromatography wherein an asymmetry identifying agent is fixed to the silica gel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012152913 | 2012-07-06 | ||
PCT/JP2013/068466 WO2014007362A1 (en) | 2012-07-06 | 2013-07-05 | Method for separating cyclic macrolide compound |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014DN11183A true IN2014DN11183A (en) | 2015-10-02 |
Family
ID=49882113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN11183DEN2014 IN2014DN11183A (en) | 2012-07-06 | 2013-07-05 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2871188B1 (en) |
JP (1) | JP6210983B2 (en) |
KR (1) | KR20150028245A (en) |
CN (1) | CN104428308B (en) |
ES (1) | ES2624229T3 (en) |
HU (1) | HUE032954T2 (en) |
IN (1) | IN2014DN11183A (en) |
TW (1) | TWI614255B (en) |
WO (1) | WO2014007362A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109406650A (en) * | 2018-10-25 | 2019-03-01 | 美康生物科技股份有限公司 | Kit and detection method for four kinds of immunosuppressant drug concentrations in Accurate Determining people's whole blood |
CN114516884B (en) * | 2022-01-05 | 2024-03-19 | 福建省微生物研究所 | Purification method of high-purity tacrolimus |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR901156A (en) | 1943-01-19 | 1945-07-19 | Degussa | Process for the production of artificial materials |
FR900525A (en) | 1943-12-13 | 1945-07-02 | Stove, especially for the outdoors | |
GB8430455D0 (en) | 1984-12-03 | 1985-01-09 | Fujisawa Pharmaceutical Co | Fr-900506 substance |
PT2198858E (en) * | 1998-03-26 | 2011-09-01 | Astellas Pharma Inc | Sustained release preparation of a macrolide compound like tacrolimus |
PL199512B1 (en) * | 1999-05-25 | 2008-09-30 | Astellas Pharma Inc | Method for separating analogous organic compounds |
TW553946B (en) | 1999-09-08 | 2003-09-21 | Fujisawa Pharmaceutical Co | Method for separating lactone-containing high-molecular weight compounds |
EP1513856A1 (en) * | 2002-05-31 | 2005-03-16 | Janssen Pharmaceutica N.V. | 3-descladinosyl-6-o-carbamoyl and 6-o-carbonoyl macrolide antibacterial agents |
CN1856500A (en) * | 2003-07-24 | 2006-11-01 | 特瓦药厂私人有限公司 | Method of purifying macrolides |
WO2005063242A1 (en) * | 2003-12-30 | 2005-07-14 | Astellas Pharma Inc. | Use of macrolides for treating or preventing airflow obstruction |
JP4515812B2 (en) * | 2004-04-28 | 2010-08-04 | ダイセル化学工業株式会社 | Separating agent for optical isomers |
CN101087796A (en) * | 2004-12-22 | 2007-12-12 | 特瓦药厂私人有限公司 | Method of purifying tacrolimus |
CN101712685B (en) * | 2009-06-22 | 2012-07-04 | 鲁南制药集团股份有限公司 | Refining method of crude tacrolimus |
-
2013
- 2013-07-05 ES ES13813495.2T patent/ES2624229T3/en active Active
- 2013-07-05 JP JP2014523801A patent/JP6210983B2/en not_active Expired - Fee Related
- 2013-07-05 HU HUE13813495A patent/HUE032954T2/en unknown
- 2013-07-05 EP EP13813495.2A patent/EP2871188B1/en not_active Not-in-force
- 2013-07-05 KR KR1020147035002A patent/KR20150028245A/en not_active Application Discontinuation
- 2013-07-05 CN CN201380035718.8A patent/CN104428308B/en not_active Expired - Fee Related
- 2013-07-05 TW TW102124290A patent/TWI614255B/en not_active IP Right Cessation
- 2013-07-05 WO PCT/JP2013/068466 patent/WO2014007362A1/en active Application Filing
- 2013-07-05 IN IN11183DEN2014 patent/IN2014DN11183A/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2624229T3 (en) | 2017-07-13 |
CN104428308B (en) | 2016-11-09 |
EP2871188A1 (en) | 2015-05-13 |
JPWO2014007362A1 (en) | 2016-06-02 |
TW201410682A (en) | 2014-03-16 |
CN104428308A (en) | 2015-03-18 |
WO2014007362A1 (en) | 2014-01-09 |
KR20150028245A (en) | 2015-03-13 |
EP2871188B1 (en) | 2017-04-19 |
TWI614255B (en) | 2018-02-11 |
HUE032954T2 (en) | 2017-11-28 |
EP2871188A4 (en) | 2015-12-02 |
JP6210983B2 (en) | 2017-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201201288A1 (en) | METHOD OF APPLICATION OF REAGENTS OF GRINIAR | |
EP3010917A4 (en) | Novel substituted bicyclic compounds as bromodomain inhibitors | |
EP3030683A4 (en) | Protected fluorescent reagent compounds | |
CR20140463A (en) | HETEROCICLYL COMPOUNDS AS MEK INHIBITORS | |
BR112014010955A2 (en) | system and method for processing samples | |
EA201201016A1 (en) | ANTI-AUDIO ANTICOAGULANTS | |
EP3019267A4 (en) | Method of separating organofluorine compounds using membrane | |
EP3076170A4 (en) | Solid-phase carrier, production method for solid-phase carrier, carrier for affinity refining, production method for filler for affinity chromatography, filler for affinity chromatography, chromatography column, and refining method | |
WO2013022985A3 (en) | Small molecule compounds for the control of nematodes | |
EP3077618A4 (en) | Tuning digital core analysis to laboratory results | |
HK1223403A1 (en) | Method for determining nucleic acid composition of nucleic acid mixture | |
EP3033611A4 (en) | Method of tracing chemical quantities using encapsulated fluorescent dyes | |
EP3283877A4 (en) | Structural elucidation of isotopically labeled analytes | |
GB201303521D0 (en) | Process operations for biomass fractionation | |
SG11201508558QA (en) | Immobilized catalytically active composition for hydroformylation of olefin-containing mixtures | |
BR112014023570A2 (en) | CISTATIONINE BETA-SYNTASE PURIFICATION | |
EP3088424A4 (en) | Method for manufacturing (meth)acrylic resin composition | |
FR2993666B1 (en) | METHOD FOR MANUFACTURING CHROMATOGRAPHIC ENRICHMENT COLUMN | |
WO2014210416A8 (en) | Helicase suppression of non-template amplification | |
EP3059585A4 (en) | Method for manufacturing small-diameter column for chromatography | |
IN2013CH04906A (en) | ||
IN2014DN11183A (en) | ||
EA201500210A1 (en) | METHOD OF RETINOL ETHER RETERIFICATION | |
EP3059578A4 (en) | Method for detecting microorganism having fluorescent characteristics with respect to specific wavelength | |
EP3014262A4 (en) | Compensation for chromatography column volume variations |